Regeneron Pharmaceuticals reported $100K in Ordinary Share Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Agenus AGEN:US $ 2.67M 0.1M
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Alimera Sciences ALIM:US $ 0.07M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.21M 0M
Astellas Pharma 4503:JP Y 103001M 0M
AstraZeneca AZN:LN 387M 0M
Biogen BIIB:US $ 0.1M 0M
Biomarin Pharmaceutical BMRN:US $ 0.19M 0M
Bristol Myers Squibb BMY:US $ 292M 0M
Eli Lilly And LLY:US $ 594.1M 0M
Esperion Therapeutics ESPR:US $ 65K 4K
GlaxoSmithKline GSK:LN 1347M 0M
Intercept Pharmaceuticals ICPT:US $ 0.03M 0M
IONIS PHARMACEUT IONS:US $ 0.14M 0M
Kyowa Hakko Kirin 4151:JP Y 26745M 0M
Moderna Inc MRNA:US 39.2K 800
Neurocrine Biosciences NBIX:US $ 0.1M 0M
Novartis NOVN:VX SF 890M 11M
Novartis NVS:US $ 890M 11M
Ophthotech OPHT:US $ 0.12M 0M
Opthea Ltd OPT:AU 234.64M 491.7K
Puma Biotechnology PBYI:US $ 0M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Seattle Genetics SGEN:US $ 0.18M 0M
Teva Pharmaceutical TEVA:IT 57M 0
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
United Therapeutics UTHR:US $ 0.7M 0M
YTE INCY:US $ 0.22M 0M